VEOR SURGERY
SOUTH TERRACE, CAMBORNEStroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
STROKE 9 | 2005 | 177 | 226 | 78.3% | |
STROKE 9 | 2006 | 178 | 189 | 94.2% | |
Stroke 12 | 2007 | 183 | 196 | 93.4% | |
Stroke 12 | 2008 | 191 | 198 | 96.5% | |
Stroke 12 | 2009 | 187 | 198 | 94.4% | |
Stroke 12 | 2010 | 170 | 185 | 91.9% | |
STROKE 12 | 2011 | 172 | 186 | 92.5% | |
STROKE 12 | 2012 | 171 | 189 | 90.5% | |
STROKE 12 | 2013 | 174 | 192 | 90.6% | |
STIA007 | 2014 | 152 | 168 | 90.5% | |
STIA007 | 2015 | 148 | 161 | 91.9% | |
STIA007 | 2016 | 143 | 163 | 87.7% | |
STIA007 | 2017 | 140 | 154 | 90.9% | |
STIA007 | 2018 | 140 | 151 | 92.7% | |
STIA007 | 2019 | 157 | 158 | 99.4% | |
STIA007 | 2020 | 152 | 179 | 84.9% | |
STIA007 | 2021 | 168 | 198 | 84.8% | |
STIA007 | 2022 | 181 | 207 | 87.4% | |
STIA007 | 2023 | 204 | 230 | 88.7% |